UK markets open in 7 hours 40 minutes

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6000-0.1600 (-9.09%)
At close: 04:00PM EDT
1.5200 -0.08 (-5.00%)
After hours: 06:40PM EDT

DarioHealth Corp.

122 W 57th St,
#33B
New York, NY 10019
United States

https://www.dariohealth.com

Sector(s)Healthcare
IndustryHealth Information Services
Full-time employees276

Key executives

NameTitlePayExercisedYear born
Mr. Erez RaphaelCEO & Director722.19kN/A1973
Mr. Richard A. AndersonPresident536.65kN/A1969
Mr. Zvi Ben David CPACFO, Treasurer & Secretary342.58kN/A1961
Dov OppenheimCo-Founder & Production ChiefN/AN/AN/A
Mr. Tomer Ben-KikiChief Operating OfficerN/AN/A1971
Josh FischerSenior Vice President of Operations & ComplianceN/AN/AN/A
Claudia LeviContent & Communications ManagerN/AN/AN/A
Mary MooneyVice President of MarketingN/AN/AN/A
Limor DreznerChief People OfficerN/AN/AN/A
Mr. Jean Christophe MuylHead of Commercialization North AmericaN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Corporate governance

DarioHealth Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.